Tam, Friederike I. http://orcid.org/0000-0001-8333-867X
Ochmann, Richard
Marschall, Jörg http://orcid.org/0000-0001-8995-6401
Leschzinski, Henri
Seidel, Maria
Klink, Linda
Föcker, Manuel
Bühren, Katharina
Dahmen, Brigitte
Jaite, Charlotte
Herpertz-Dahlmann, Beate
Seitz, Jochen http://orcid.org/0000-0002-0110-7980
Gilsbach, Susanne
Correll, Christoph U. http://orcid.org/0000-0002-7254-5646
Müller, Antonia E.
Hebebrand, Johannes http://orcid.org/0000-0001-5364-6073
Bell, Rebecca
Legenbauer, Tanja http://orcid.org/0000-0002-1580-9991
Holtmann, Martin
Becker, Katja http://orcid.org/0000-0003-4858-5127
Weber, Linda
Romanos, Marcel http://orcid.org/0000-0001-7628-8299
Egberts, Karin http://orcid.org/0000-0002-0270-0954
Kaess, Michael
Fleischhaker, Christian
Möhler, Eva http://orcid.org/0000-0001-5620-1563
Wessing, Ida http://orcid.org/0000-0001-8248-6814
Hagmann, Daniela http://orcid.org/0000-0003-2389-154X
Hahn, Freia
Thiemann, Ulf
Antony, Gisela
Gramatke, Katrin
Roessner, Veit
Ehrlich, Stefan http://orcid.org/0000-0003-2132-4445
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 16 November 2023
Accepted: 5 July 2024
First Online: 20 July 2024
Declarations
:
: F. T. and S. E. have received a research grant from the “Marga and Walter Boll-Stiftung”. F. T. has received a research grant from the B. Braun Stiftung and funding from the Medical Faculty of the Technische Universität Dresden (“Habilitation Funding for Women”). S. E. has received funding by the Deutsche Forschungsgemeinschaft (EH 367/5-1, EH 367/7-1 and SFB 940), the Swiss Anorexia Nervosa Foundation and the Ingvild Goetz Philanthropy. C. C. has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Adock Ingram, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Bristol-Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Sage, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Takeda, Teva, Tolmar, Vertex, and Viatris. C. C. provided expert testimony for Janssen and Otsuka. C. C. served on a Data Safety Monitoring Board for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. C. C. has received grant support from Janssen and Takeda. C. C. received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Mindpax, and Quantic. J. H. was named as inventor in three patent filings of the University of Duisburg-Essen for treatment of anorexia nervosa, related eating disorders and depression with leptin analogues. K. B. receives or has received research grants from the German Research Foundation (DFG), German Federal Ministry for Education and Research (BMBF), Philipps-University Marburg, Federal Joint Committee (G-BA), German Ministry for Health, University Hospital Giessen and Marburg and Rhön Klinikum AG. Further, K. B. receives royalties and honorary from Georg Thieme Publisher. T. L. received funding from the Federal Ministry of Education and Research (BMBF) as well as the Swiss Anorexia Nervosa Foundation for research projects and royalities for text books and treatment manuals from Hogrefe, Kohlhammer, Springer and DeGrutyter. V. R. has received payment for consulting and writing activities from Eli Lilly and Co., Novartis and Shire Pharmaceuticals/Takeda, lecture honoraria from Eli Lilly and Co., Novartis, Shire Pharmaceuticals/Takeda, and Medice Pharma, and support for research from Shire Pharmaceuticals/Takeda and Novartis. V. R. has carried out (and is currently carrying out) clinical trials in cooperation with Novartis, Shire Pharmaceuticals/Takeda and Otsuka. V. R. has no financial relationship with the organizations that sponsored the research. All other authors declare no competing interests.